Leaflet OLYSIO 150mg capsules
Indicated for: chronic hepatitis C
Route of administration: oral
Substance: simeprevir (antiviral)
ATC: J05AE14 (Antiinfectives for systemic use | Direct acting antivirals | Protease inhibitors)
Dose adjustment may be needed in kidney disease.
This medicine may have important interactions with other medicines.
Use during breastfeeding only on medical advice.
Use during pregnancy only on medical advice.
Simeprevir is an antiviral medication used for the treatment of chronic hepatitis C, usually in combination with other antiviral drugs. It works by inhibiting the NS3/4A protein of the hepatitis C virus, preventing viral replication.
The medication is taken orally, as directed by a doctor, usually once daily. It is important for patients to follow the treatment regimen and undergo regular check-ups to monitor the response to therapy.
Patients should be aware of potential side effects, such as skin rashes, nausea, or elevated bilirubin levels. It is important to inform the doctor of any unusual symptoms.
Common side effects include skin rashes, nausea, and elevated bilirubin levels. In rare cases, severe reactions such as allergic reactions or liver failure may occur. Patients should be informed of these risks before starting treatment.
General data about OLYSIO 150mg
- Substance: simeprevir
- Date of latest medicines list: 01-01-2019
- Product code: W60938001
- Concentration: 150mg
- Pharmaceutical form: capsules
- Quantity: 28
- Product type: Original
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.